Publications by authors named "Amany M Rabah"

Background: A central role for apolipoprotein E (APOE) has been suggested in modulating processes of neurodegeneration.

Objective: To study the association between serum APOE levels, APOE gene polymorphisms, and Parkinson's disease (PD).

Material And Methods: Fifty-five patients with PD and 30 healthy subjects were enrolled.

View Article and Find Full Text PDF

Background: Despite multiple diagnostic tests, multiple sclerosis (MS) remains a clinical diagnosis with supportive paraclinical evidence.

Objective: To measure glutamate and nitric oxide serum levels in MS patients during and in between relapses to assess their potential role as biomarkers of disease activity and relapses.

Subjects And Methods: This cross sectional study was carried out on 70 MS patients and 40 age and sex matched apparently healthy controls.

View Article and Find Full Text PDF

Introduction: Epilepsy is a chronic disease that affects metabolism either alone or through the antiepileptic drug (AED) treatment. A risk of atherosclerosis has been found in epileptic patients.

Aim: Prove the potential role of epilepsy and/or its treatment as atherosclerotic risk factors.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Amany M Rabah"

  • - Amany M Rabah's research primarily focuses on the intersections of neurological disorders and metabolic processes, particularly in conditions such as Parkinson’s disease, multiple sclerosis, and epilepsy.
  • - Recent findings indicate a significant association between serum apolipoprotein E levels and gene polymorphisms in relation to Parkinson's disease, suggesting potential biomarkers for neurodegeneration.
  • - Additionally, studies have explored the roles of glutamate and nitric oxide as biomarkers for disease activity in multiple sclerosis, and the implications of epilepsy and related treatments as potential risk factors for atherosclerosis.